Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
BMGL
Strong SellBasel Medical Group Ltd · Healthcare · Singapore · $122M · Avg Vol: $78K/d
3
StockRankGet insider-trade alerts
Q
15
V
38
M
15
P/E (TTM)
—
ROE
-147.4%
D/E
1.5x
Dividend %
—
COMPANY DESCRIPTION
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic...
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 8.4M | 7.6M | 7.9M | 8.9M | 2.0% | 11.6M |
| EPS | 1.13 | 0.89 | 1.04 | -5.33 | -3.9% | -5.82 |
| Shares | 1.6M | 1.6M | 1.6M | 1.6M | 0.0% | 1.6M |
| Debt | 8.0M | 5.7M | 3.4M | 4.0M | -20.6% | 7.8M |
| Equity | 2.9M | 4.3M | 5.9M | 4.3M | 13.6% | — |
| Op CF | 2.2M | 2.0M | 2.0M | -2.5M | -5.2% | -1.5M |
| Inv CF | -69.4K | -4.8K | -6.2K | -6.7M | — | — |
| Fin CF | -10.1M | -2.3M | -1.4M | 10.2M | — | — |
Loading 1Y...
PRICE (1Y)-2.8%
SMA 50SMA 200
Close
$5.24
RSI (14)
53.9
52W High
$25.80
From 52W High
0.2%
SCORE BREAKDOWN
Quality
15
ROIC
-127.4%5.1
ROE
-147.4%6.3
GP/Assets
11.1%28.9
Op. Margin
-32.8%23.6
FCF/Assets
n/mN/A
Piotroski
26.0
Int. Cover
-50.0x6.2
D/E Ratio
1.51x8.8
Current Ratio
1.89x36.3
Value
38
P/E (TTM)
—N/A
EV/EBITDA
-3.4x25.0
P/FCF
n/mN/A
P/B
2.4x53.8
P/S
0.8x86.9
Div Yield
—N/A
Momentum
15
52W High %
20%3.4
RS 6M
-40%22.0
SMA 50/200
0.75x13.7
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$122M
P/E (Forward)
—
Gross Margin
14.0%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BMGL are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BMGL | Basel Medical Group Ltd(you) | $122M | 3 | Strong Sell |
| 1D4.SI | Aoxin Q & M Dental Group Limited | $196M | 42 | Hold |
| A50.SI | Thomson Medical Group Limited | $1.1B | 29 | Sell |
| QC7.SI | Q & M Dental Group (Singapore) Limited | $410M | 52 | Hold |
| FHH.SI | Foundation Healthcare Holdings Limited | $747M | 56 | Hold |
| 5WA.SI | OUE Healthcare Limited | $168M | 88 | Strong Buy |
| BSL.SI | Raffles Medical Group Ltd | $1.3B | 72 | Buy |
| 8YY.SI | Embracing Future Holdings Limited | $54M | 3 | Strong Sell |
| 950210.KS | Prestige BioPharma Limited | $269M | 7 | Strong Sell |
| 2629.HK | Mirxes Holding Company Limited | $472M | 18 | Strong Sell |
Peer medians: ROE 5.2% · P/E 18.4x · Gross margin 43.9%